The city of Phoenix, Arizona, currently has 3 active clinical trials seeking participants for Depression research studies.
Wellness App for Sleep Disturbance in Hematological Cancer Patients
Recruiting
In a randomized controlled trial (RCT), the investigators will recruit participants to an 8-week "app-based wellness" intervention, followed by a 12-week follow-up period. The investigators will recruit a total of 276 self-declared Chronic Hematological Cancer (CHC) patients who (representative of age, race/ethnicity, and gender) will be on stable CHC pharmacologic therapy (if any), self-identify as sleep disturbed (>5 on Pittsburgh Sleep Quality Index), do not have a sleep disorder diagnosis, d... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/22/2024
Locations: Arizona State University, Phoenix, Arizona
Conditions: Cancer, Sleep Disturbance, Anxiety, Depression, Inflammation, Fatigue
A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
Recruiting
This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as an adjunctive treatment of Major Depressive Disorder. Study participants will continue to take their current antidepressant therapy in addition to the study drug or placebo for the duration of the treatment period.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
02/15/2024
Locations: Relmada Site, Phoenix, Arizona +1 locations
Conditions: Major Depressive Disorder, Depression
Anaerobic Exercise and Mental Acuity
Recruiting
This is a randomized controlled trial to examine the effect of anaerobic activity (e.g., weight training) on gut microbiome metabolism and neurological health in healthy sedentary men.
Gender:
Male
Ages:
Between 18 years and 60 years
Trial Updated:
05/08/2023
Locations: 850 PBC, Phoenix, Arizona
Conditions: Depression, LPS, Mood